Who will head the ERC?

The European Research Council looks for a chief executive, releases launch strategy

Written byStephen Pincock
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
With only days to go until applications close for the post of secretary general of the European Research Council, scientists in the European Union (EU) are watching closely to see who will be appointed to the challenging position.The head of the new EU science funding body will need to have substantial scientific and political clout, plus a dedication to funding based on peer review, senior EU science figures told The Scientist. "I think there are dozens of excellent people who have a good combination of science and scientific policy who could do the job," said Frederic Sgard, vice-president of Euroscience. The ERC has been a major talking-point in EU science for years. It is envisaged as an independent funding body that will support fundamental science on the basis of peer-review, not the matrix of social and political agendas that constrain other forms of EU funding.In late April, the ERC's 22-member scientific council announced it was seeking candidates for the job of secretary general -- who will, in effect, be the agency's chief executive officer, reporting to the scientific council and working with a director nominated by the European Commission. The deadline for applications is May 31.The scientific council said in a statement that they want to appoint someone with a balance of scientific stature and policy clout. The successful candidate will need to have a proven track record at the top of a peer-review based funding agency.Identifying someone who meets all those criteria will not be easy, said Neil Williams, senior science officer at the European Science Foundation. "It's quite a challenging job," he told The Scientist. "He or she is clearly going to have to work with a lot of stakeholders in research, including the commission and big national research agencies." Another important priority must be the candidate's willingness to insist on funding according to excellence alone, Williams added. "If he or she isn't able to do that, the scientific community's hopes for [the ERC] will be disappointed and its reputation damaged."One leading candidate among this potentially crowded field may be the molecular biologist Ernst-Ludwig Winnacker, outgoing president of Germany's national research funder, the Deutsche Forschungsgemeinschaft (DFG)."Germany is applying pressure to have either the secretary general or the director of the executive agency," said Luc Van Dyck, executive coordinator of the European Life Sciences Forum. Winnacker is a prime candidate for the job and fits many important criteria, he added, particularly given his long advocacy for the creation of the ERC, due begin operations in 2007.Tim Hunt, Nobel laureate from Cancer Research UK, commented that he had been impressed with the way he's seen the DFG, under Winnacker, deal with peer review for grant applications. "I think they just did it right," he said. Another thing in Winnacker's favor is the fact his nine-year tenure as president of the DFG ends in December. "A key consideration is when the person is available," Van Dyck said. "The current head of any funding body will probably need a year before they can start, but the ERC needs to appoint someone soon. Someone who is readily available will be hard to find."Winnacker declined to comment for this story.In April, the ERC publicly released its launch strategy, which specifies that ERC funding will be awarded "on the basis of excellence." Its initial funding mechanism will focus on helping young scientists set up their own research teams in Europe, while a secondary mechanism will focus on more senior researchers. This is good news, said Sgard. "I would definitely say that they young scientists are the priority," he said. "That is where we have a problem in Europe."More broadly, scientists are pleased with the way the agency is developing, Van Dyck said. "I think that the scientific community is astonished that it is going so fast and that it is so on track. They are also happy that the scientific council has been consulting them. I think this is seen as very positive." Tim Hunt agreed, saying he had "great faith" in the ERC.Still, there are numerous hurdles still ahead. Crucially, the agency needs to find a way to balance power within its three-headed leadership. The scientific council, the secretary general, and the director will all have roles to play, and "great care needs to be taken when these people are chose so there is no conflict," said Van Dyck.Stephen Pincock spincock@the-scientist.comLinks within this articleCall for applications for the post of ERC Secretary General europa.eu.int/erc/pdf/sec-gen-recruit_en.pdfFrederic Sgard www.euroscience.org/MBSHIP/bmembercv.htmJ. Burgermeister, "ERC scientific council named," The Scientist, July 19, 2005. www.the-scientist.com/article/display/22733/Neil Williams www.esf.org/esf_genericpage.php?language=0§ion=8&genericpage=672Ernst-Ludwig Winnacker www.dfg.de/en/dfg_profile/structure/statutory_bodies/executive_board/members_executive_board/ernst_ludwig_winnacker.htmlEuropean Life Sciences Forum www.elsf.org/X. Bosch, "Concern over ERC funding," The Scientist, July 26, 2005. www.the-scientist.com/article/display/22739/Tim Hunt science.cancerresearchuk.org/research/loc/london/lifch/huntt/The ERC Launch Strategy europa.eu.int/erc/pdf/launch-strategy_en.pdf
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform